Editorial (Thematic Issue: New Trends in Pharmaceutical Nanotechnology)
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
5169-5171
Author(s):
Marilene Estanqueiro, M. Helena Amaral and Jose Manuel Sousa Lobo
Update on Pharmacologic Retinal Vascular Toxicity
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
4694-4697
Author(s):
Stephen G. Schwartz, Andrzej Grzybowski, Weronika Wasinska-Borowiec, Harry W. Flynn and William F. Mieler
Bio-Distribution, Imaging Protocols and Diagnostic Accuracy of PET with Tracers of Lipogenesis in Imaging Prostate Cancer: a Comparison between 11C-Choline, 18FFluoroethylcholine and 18F-Methylcholine
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
4738-4747
Author(s):
Ferdinando Calabria, Gianpasquale Gallo, Orazio Schillaci and Giuseppe Lucio Cascini
The GABAergic System and the Gastrointestinal Physiopathology
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
4996-5016
Author(s):
Michelangelo Auteri, Maria Grazia Zizzo and Rosa Serio
The Holy Grail of Polymer Therapeutics for Cancer Therapy: An Overview on the Pharmacokinetics and Bio Distribution
Journal:
Current Drug Metabolism
Volume:
16
Page:
522-537
Author(s):
Sathish Dyawanapelly, Vijayabhaskar Reddy Junnuthula and AkhileshVikram Singh
Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging
Journal:
Current Medicinal Chemistry
Volume:
22
Page:
3631-3651
Author(s):
Gunter Almer, Harald Mangge, Andreas Zimmer and Ruth Prassl
Novel and Emerging Targeted Therapies of Colorectal Cancer
Journal:
Current Clinical Pharmacology
Volume:
10
Page:
279-298
Author(s):
Niklas Finnberg, Prashanth Gokare and Wafik S. El-Deiry
Trends in Malignant Glioma Monoclonal Antibody Therapy
Journal:
Current Cancer Therapy Reviews
Volume:
11
Page:
102-118
Author(s):
Ivan Chekhonin and Olga Gurina
Application of Glutathione as Anti-Oxidative and Anti-Aging Drugs
Journal:
Current Drug Metabolism
Volume:
16
Page:
560-571
Author(s):
Takujiro Homma and Junichi Fujii
Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets
Journal:
Current Genomics
Volume:
17
Page:
33-61
Author(s):
A. Porrello and R. Piergentili